Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of convening an emergency taskforce to address current medicine shortages.

There are no plans to convene a taskforce on medicine shortages.

There are around 14,000 licensed medicines and the overwhelming majority are in good supply. Medicine supply chains are complex, global and highly regulated and there are a number of reasons why supply can be disrupted. Many of these are not specific to the United Kingdom and outside of Government control, including manufacturing difficulties, access to raw materials, sudden demand spikes or distribution and regulatory issues.

To help manage these risks, the Department and NHS England are committed to strengthening long term supply chain resilience and continually improving how we prevent, mitigate, and manage supply issues to protect patients from shortages.

The Department, working closely with NHS England, is taking forward a range of actions to further strengthen our ability to anticipate, mitigate, and manage shortages. As part of that work, we continue to engage with industry, the Medicines and Healthcare products Regulatory Agency, and other colleagues across the supply chain. However, medicine shortages are a complex and global issue, and improving resilience requires action from all parts of the supply chain through a collaborative approach.

In August 2025, the Department published a policy paper, Managing a robust and resilient supply of medicines, which provides greater transparency of the supply chains we rely on, the actions we take to protect patients from medicines shortages when they occur, and the steps being taken to strengthen resilience. Later this year, we will publish an update on progress against those commitments and set out further actions to strengthen the resilience of our medicines supply chains. The paper is available at the following link:

https://www.gov.uk/government/publications/managing-a-robust-and-resilient-supply-of-medicines/managing-a-robust-and-resilient-supply-of-medicines